Logo Lanfrica

LENACAPAVIR FOR HIV PRE-EXPOSURE PROPHYLAXIS IN SUB-SAHARAN AFRICA: A Scoping Review of Health System Readiness and Implementation Barriers

Domaine:

healthcare
Créateur:
AfoDamMayAde
Éditeur:
Cen
Éditeur:
OSF
Hôte:avatar
The primary research question, structured using the PICO framework, was: Among HIV-negative individuals at risk in SSA (P), what is the evidence on lenacapavir as HIV PrEP (I) compared with alternative PrEP modalities (C), regarding efficacy, implementation feasibility, health system readiness, and equity outcomes (O)?

Tags

Medicine and Health Sciences

Licenses

Creative Commons Zero v1.0 Universalhttps://creativecommons.org/publicdomain/zero/1.0/legalcode

Similaires

<b>Pre-exposure Prophylaxis (PrEP) implementation among People Who Inject Drugs (PWID) in Sub-Saharan Africa: A scoping review of Implementation determinants (barriers and facilitators) and Implementation strategy.</b>

Background: Sub-Saharan Africa (SSA) has suffered the greatest impact of the global HIV pande

A Systematic Review of Barriers and Facilitators to Long-Acting HIV Pre-Exposure Prophylaxis Uptake among Key Populations in Nigeria: Implications for Lenacapavir.

Background: Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) offers a promising strategy f

Health System Readiness for the Implementation of Primaquine-Based Malaria Elimination Strategies in Sub-Saharan Africa: A Scoping Review

This scoping review will examine health-system readiness for the implementation of primaquine-based

<b>Pre-exposure prophylaxis implementation determinants and strategies for uptake and utilization during periconception period among women in sub-Saharan Africa: A scoping review protocol</b>

Background: HIV-negative women attempting conception with partners living with HIV or of unkn

Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation

Background South Africa accounts for 20% of global HIV infections. Six-monthly

User preferences on long-acting pre-exposure prophylaxis for HIV prevention in Eastern and Southern Africa: a scoping review

Abstract Background Novel formulations for pre-exposure prophylaxis (PrEP) such as injectables, impl